Cargando…

Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis

BACKGROUND: Aspirin has been recommended for the prevention of major adverse cardiovascular events (MACE, composite of non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death) in diabetic patients without previous cardiovascular disease. However, recent meta-analyses have prompte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butalia, Sonia, Leung, Alexander A, Ghali, William A, Rabi, Doreen M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098148/ https://www.ncbi.nlm.nih.gov/pubmed/21453547 http://dx.doi.org/10.1186/1475-2840-10-25

Ejemplares similares

To test or not to test? Self-monitoring of blood glucose in patients with type 2 diabetes managed without insulin
por: Butalia, Sonia, et al.
Publicado: (2010)

Sex-based disparities in cardioprotective medication use in adults with diabetes
por: Butalia, Sonia, et al.
Publicado: (2014)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

New genetic variants associated with major adverse cardiovascular events in patients with acute coronary syndromes and treated with clopidogrel and aspirin
por: Liu, Xiaomin, et al.
Publicado: (2021)

The Challenges of Identifying Environmental Determinants of Type 1 Diabetes: In Search of the Holy Grail
por: Butalia, Sonia, et al.
Publicado: (2020)

Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme
por: Dougados, Maxime, et al.
Publicado: (2023)

Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study
por: Vidyanti, Amelia Nur, et al.
Publicado: (2019)

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib
por: Kristensen, Lars E., et al.
Publicado: (2023)

Residual Risk Factors to Predict Major Adverse Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with and without Diabetes Mellitus
por: Lin, Fang-Ju, et al.
Publicado: (2017)

Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus
por: Fu, Liyao, et al.
Publicado: (2021)

Correction: Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study
por: Vidyanti, Amelia Nur, et al.
Publicado: (2020)

Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors
por: Miao, Benjamin, et al.
Publicado: (2020)

A Systematic Review and Meta-Analysis of the Incidence and Risk Factors for Major Adverse Cardiovascular Events in Patients with Unrepaired Abdominal Aortic Aneurysms
por: Sharma, Chinmay, et al.
Publicado: (2023)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus
por: Xing, Zhenhua, et al.
Publicado: (2020)

Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention
por: Ramesh, S., et al.
Publicado: (2020)

Genetic information improves the prediction of major adverse cardiovascular events in the GENEMACOR population
por: Mendonça, Maria Isabel, et al.
Publicado: (2021)

Systematic review and meta-analysis: SGLT2 inhibitors, blood pressure and cardiovascular outcomes
por: Benham, Jamie L., et al.
Publicado: (2021)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events
por: Uyan, Umut
Publicado: (2023)

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational Studies
por: Armstrong, Ehrin J., et al.
Publicado: (2013)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection
por: Jiang, Joy, et al.
Publicado: (2023)

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins
por: De Berardis, Giorgia, et al.
Publicado: (2007)

Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events
por: Sylvester, Katelyn W, et al.
Publicado: (2013)

Association of Lipoprotein(a) Levels With Incidence of Major Adverse Limb Events
por: Guédon, Alexis F., et al.
Publicado: (2022)

Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations
por: Khokhar, Bushra, et al.
Publicado: (2016)

Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
por: Armstrong, Ehrin J., et al.
Publicado: (2014)

Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis
por: Muñoz-Bravo, Carlos, et al.
Publicado: (2023)

Long‐Term Blood Pressure Variability and Major Adverse Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage
por: Castello, Juan Pablo, et al.
Publicado: (2022)

Heterogeneous plaque–lumen geometry is associated with major adverse cardiovascular events
por: Gu, Sophie Z, et al.
Publicado: (2023)

Six month incidence of major adverse cardiovascular events among adults with HIV in northern Tanzania: a prospective observational study
por: Stark, Kristen, et al.
Publicado: (2023)

Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain
por: González-Juanatey, Carlos, et al.
Publicado: (2023)

Association of Uncontrolled Hypertension or Diabetes Mellitus With Major Adverse Cardiovascular Events and Mortality in South Korea: Population-Based Cohort Study
por: Oh, Sung-Hee, et al.
Publicado: (2023)

Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
por: Cai, Anping, et al.
Publicado: (2019)

Myocardial Injury Is Associated with the Incidence of Major Adverse Cardiac Events in Patients with Severe Trauma
por: Stroda, Alexandra, et al.
Publicado: (2022)

Incidence of adverse cardiovascular events in patients with insomnia: A systematic review and meta-analysis of real-world data
por: Ali, Eman, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q6apo7e5ugnkius39av894p419